Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:208641.
doi: 10.1155/2012/208641. Epub 2012 Jul 9.

A Comparative Interaction between Copper Ions with Alzheimer's β Amyloid Peptide and Human Serum Albumin

Affiliations

A Comparative Interaction between Copper Ions with Alzheimer's β Amyloid Peptide and Human Serum Albumin

G Rezaei Behbehani et al. Bioinorg Chem Appl. 2012.

Abstract

The interaction of Cu(2+) with the first 16 residues of the Alzheimer's amyliod β peptide, Aβ(1-16), and human serum albumin (HSA) were studied in vitro by isothermal titration calorimetry at pH 7.2 and 310 K in aqueous solution. The solvation parameters recovered from the extended solvation model indicate that HSA is involved in the transport of copper ion. Complexes between Aβ(1-16) and copper ions have been proposed to be an aberrant interaction in the development of Alzheimer's disease, where Cu(2+) is involved in Aβ(1-16) aggregation. The indexes of stability indicate that HSA removed Cu(2+) from Aβ(1-16), rapidly, decreased Cu-induced aggregation of Aβ(1-16), and reduced the toxicity of Aβ(1-16) + Cu(2+) significantly.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison between the experimental heats (O) at 310 K, for HSA + Cu2+ interactions and the calculated data (lines) via (1). [Cu2+] values are the concentrations of [Cu(NO3)2] solution in μM.
Figure 2
Figure 2
Comparison between the experimental heats (O) at 310 K, for (1–16) + Cu2+ interactions and the calculated data (lines) via (1). [Cu2+] values are the concentrations of [Cu(NO3)2] solution in μM.

References

    1. Watanabe H, Kragh-Hansen U, Tanase S, et al. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochemical Journal . 2001;357(1):269–274. - PMC - PubMed
    1. Peters T. Serum albumin. Advances in Protein Chemistry . 1985;37:161–245. - PubMed
    1. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release . 2008;132(3):171–183. - PubMed
    1. Behbehani GR, Divsalar A, Saboury AA, Bagheri MJ. A thermodynamic study on the binding of human serum albumin with new synthesized anti cancer Pd (II) complex. Journal of Solution Chemistry . 2008;37(12):1785–1794.
    1. Carter DC, Ho JX. Structure of serum albumin. Advances in Protein Chemistry . 1994;45:153–203. - PubMed

LinkOut - more resources